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1.1. Indolylquinone insulin mimics
Asterriquinones are tryptophan-derived fungal natural
products that consist of a central quinone ring bearing
two prenyl-substituted indoles. Various biological activities
have been ascribed to these structures including activation
of the human insulin receptor and oral insulin mimetic
activity in mice by desmethylasterriquinone (DAQ) B1
(1). The essential pharmacophore of DAQ B1 is repre-
sented by the analogue ZL-196 (2) which has oral activity
in lowering glucose transiently in non-diabetic and persis-
tently in diabetic mice.N
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(3)Access to wider range of analogues for biological evalua-
tion against a range of targets is a desirable objective and
has initiated the synthesis and evaluation of an unbiased li-
brary of a large number of indolylquinones.1 A process has
been devised that allows the preparation of an asterriqui-
none library by the sequential introduction of a ﬁrst indole
to dichlorobenzoquinone under Brønsted acid-catalysed
conditions, followed by the introduction of a second indole
under Lewis acid catalysis. Finally, the dichlorobenzo-
quinones were hydrolysed to dihydroxybenzoquinones.
This process generates carbon-carbon bonds without the
use of air- or water-sensitive reagents or conditions, anddoi:10.1016/j.comche.2007.09.001
E-mail: nterrett@ensemblediscovery.comalso permits introduction of a wide range of indoles to
enhance library diversity.
A total of 269 analogues that passed quality control stan-
dards were prepared, and these were screened for their
potential to activate the human insulin receptor tyrosine
kinase domain expressed in an engineered CHO cell line.
Compounds were screened initially at 10-30 lM, and active
compounds then retested at 1, 3 and 10 lM to estimate
potency. Four compounds, including (3), were selected as
comparable with DAQ B1 and ZL-196 with activity in
the low micromolar range. It was subsequently noted that
the cytotoxicity observed with asterriquinone analogues
followed a diﬀerent SAR from insulin receptor activation,
suggesting that it would be possible to further develop
compounds separating these two properties.1.2. A library with antiproliferative activity on human
leukemia HL-60 cells
Although leukemia is the commonest form of cancer in
children, it is diagnosed both in adults and children and
presents a considerable medical challenge. Chemotherapy
is the most eﬀective treatment available, using various anti-
cancer drugs, although long-term eﬀectiveness is limited by
dose-related cardiotoxicity and acquired drug-resistance.
New treatments are still being sought, and a steroid pos-
sessing a methylpiperazine sidechain, reported to inhibit
HL-60 leukemia cell proliferation, has provided a starting
point for the design of a novel library of compounds.2
The aminosteroid (4) provided the starting point for library
work, and a range of derivatives were prepared in three
50 N. K. Terrett / Combinatorial Chemistry - An Online Journal 9 (2007) 49–52separate libraries using solid-phase synthesis. The key
intermediate (5) was loaded onto a chlorosilyl derivatised
polystyrene resin by attachment to the 17-hydroxy group,
and following deprotection of the piperazine, diversity
was incorporated onto the secondary amine. Individual
compounds were generated that were pure enough for
assay in an HL-60 leukemia cell proliferation assay.OH
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(5)Several compounds were identiﬁed that demonstrated
superior antiproliferative and cytotoxic activity to the lead
compound (4). In particular, it was found that the best
activity resided in compounds with a proline and lipophilic
carboxylic acid on the piperazine. For example, compound
(6) provided 58% inhibition of HL-60 cell growth at 1 lM.
Further aminosteroids are in preparation.OH
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2.1. Solid-phase synthesis
Acceleration of the Cu(I)-mediated Huisgen 1,3-dipolar
cycloaddition (Sharpless ‘click reaction’) by non-basic
histidine derivatives has been observed. An eﬃcient ‘self-
activating’ click reaction between the azide- and acetyl-
ene-containing peptides on solid-phase has also been
achieved by introducing the Nim-benzylhistidine residue
on reacting peptides.3
A simple polymer supported cyclisation-cleavage method
has been described for the small-scale synthesis of cyclic
oligodepsipeptides with 15 to 27 ring atoms per repeat unit.
In selected cases, the cyclic monomers were isolated and
characterised. If the cyclic oligomers are needed for the
preparation of static or dynamic combinatorial libraries
of macrocycles or for entropically-driven ring-opening
polymerisations, all members of the family of macrocyclicoligomers are of interest as they all react through equilibra-
tion to give the same products.4
An eﬃcient approach for the synthesis of 3-alkyl-8-aryla-
mino-1H-imidazo[4,5-g]quinazolin-2(3H)-thiones and 3-
alkyl-8-arylamino-1H-imidazo[4,5-g]quinazolin-2(3H)-ones
on solid phase has been developed. The reaction conditions
were easily applied and the products were obtained in
good yields and purities after their cleavage from the
resin.5
There are a wide variety of methods for forming C–N
bonds on solid support. Two preferred methods are reduc-
tive aminations with resin bound amines or aldehydes as
well as standard alkylation strategies. A recent paper
discloses the scope and application of the Mitsunobu reac-
tion of 2,4-dinitro-N-phenylbenzenesulphonamides derived
from both electron-rich and electron-poor anilines as a
practical and versatile addition to the repertoire of solid
phase C–N bond forming reactions.6
With the aim of ﬁnding good conditions to incorporate
hydrazino moieties into peptidic sequences of biological
interest, two strategies towards solid-phase synthesis of
hydrazinopeptides have been developed: a stepwise
methodology in which a hydrazinoacid was introduced as
a normal aminoacid and a semi-convergent one in which
the hydrazino moiety is incorporated as a pseudodipeptide
building block.7
2.2. Solution-phase synthesis
No papers this month.
2.3. Scaﬀolds for combinatorial libraries
A practical strategy has been developed for delivering 2,6-
dideoxy sugars and uncommon sugars with 4-substitution.
This approach employed the Ferrier rearrangement reac-
tion and BF3ÆOEt2-induced peroxidation to construct key
intermediate 2,3-unsaturated glycosides and a,b-unsatu-
rated lactones from peracetyl rhamnal. After further deri-
vatisation, four uncommon sugars with 4-substitution
and eight uncommon sugar units with 3,4-disubstitution
were successfully synthesised.8
2.4. Solid-phase supported reagents
No papers this month.
2.5. Novel resins, linkers and techniques
No papers this month.
2.6. Library applications
A small library of unusual biphenyl and terphenyl-contain-
ing spirocyclic triones has been synthesised in parallel by
combining the organocatalytic three-component domino
Knoevenagel/Diels–Alder sequence to Suzuki coupling.
This methodology is fast, general and serves as a platform
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protein interactions.9
The biological properties of disubstituted 2,5-diketopipera-
zines and the corresponding synthetic procedures that
allow the generation of large arrays of derivatives with
interesting biological applications have been described.10
Quinoline-2,4-dicarboxylic acids (QDCs) bearing lipophilic
substituents in the 6- or 7-position have been shown to be
inhibitors of the glutamate vesicular transporter
(VGLUT). Using the arrangement of the QDC lipophilic
substituents as a template, libraries of X1X2EF and
X1X2EW tetrapeptides were synthesised and tested as
VGLUT inhibitors, with the peptides QIEW and WNEF
found to be the most potent. Further stereochemical
deconvolution of these two peptides showed dQlIdElW to
be the best inhibitor.11
Syntheses of the pladienolide B and FD-895 side-chains, as
well as models of the essential ring-closing metathesis and
Stille coupling that will be used to complete their total syn-
theses have been reported. Several analogs of the pladieno-
lide B side-chain were also prepared in order to evaluate
the scope of the methodology and to create a library of
structures that could be used for stereochemical and SAR
analyses.12
A novel series of arylsulphonamides has been prepared
either by automated parallel or by traditional solution-
phase synthesis. Several members of this compound library
were identiﬁed as high-aﬃnity dopamine D3 and D2 recep-
tor ligands, and the most interesting representative showed
potent antipsychotic behaviour coupled with a beneﬁcial
cognitive and EPS proﬁle.13
Structure-based design of libraries of multi-component
reaction products has yielded novel potent anti-tuberculo-
sis compounds. The synthetic approach and some prelimin-
ary biological results have been presented.14
Farnesylation, catalysed by protein farnesyltransferase
(FTase), is an important post-translational modiﬁcation
guiding cellular localisation. Predictive models for identify-
ing FTase substrates through the screening of a library of
dansylated-GCaaS peptides has been undertaken, and this
also provides new insights into the protein substrate selec-
tivity of FTase.15
Cyclic peptides have been obtained on-resin, by the copper
(I) catalysed 1,3-dipolar cycloaddition of azides and
alkynes. The reaction led exclusively to the formation of
the expected cyclomonomeric products which acted as
ligands of the Vascular Endothelial Growth Factor recep-
tor 1.16
Fifteen novel C5 analogues of thiolactomycin have been
synthesised and assessed for their in vitro mtFabH and
in vivo Mycobacterium bovis BCG activity. The biological
analysis of this library reaﬃrms the requirement for a
linear p-rich system containing hydrogen bond accepting
substituents attached to the para-position of the C5biphenyl analogue to generate compounds with enhanced
activity.17References
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